| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 23 | 2021 | 739 | 3.580 |
Why?
|
| Interferon Regulatory Factors | 10 | 2020 | 69 | 3.000 |
Why?
|
| Plasma Cells | 7 | 2021 | 84 | 1.650 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 4 | 2020 | 135 | 1.420 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 308 | 1.390 |
Why?
|
| Cell Differentiation | 15 | 2021 | 1525 | 1.310 |
Why?
|
| Transplantation Tolerance | 4 | 2020 | 138 | 1.030 |
Why?
|
| Germinal Center | 4 | 2021 | 55 | 0.900 |
Why?
|
| Immunologic Memory | 6 | 2023 | 163 | 0.850 |
Why?
|
| Antibody Formation | 2 | 2020 | 171 | 0.790 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 65 | 0.760 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 1976 | 0.700 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 6 | 1999 | 105 | 0.690 |
Why?
|
| Transcription Factors | 9 | 2020 | 1653 | 0.600 |
Why?
|
| Mice | 27 | 2023 | 11761 | 0.530 |
Why?
|
| Graft Rejection | 7 | 2017 | 1070 | 0.520 |
Why?
|
| Animals | 37 | 2023 | 27371 | 0.520 |
Why?
|
| Immunity, Humoral | 2 | 2017 | 66 | 0.510 |
Why?
|
| Signal Transduction | 9 | 2020 | 3385 | 0.500 |
Why?
|
| Repressor Proteins | 5 | 2006 | 423 | 0.490 |
Why?
|
| Heart Transplantation | 6 | 2017 | 717 | 0.460 |
Why?
|
| Isoantibodies | 5 | 2020 | 119 | 0.440 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 2021 | 116 | 0.420 |
Why?
|
| Immunoglobulin Class Switching | 3 | 2022 | 37 | 0.420 |
Why?
|
| Organ Transplantation | 2 | 2015 | 276 | 0.390 |
Why?
|
| B-Lymphocytes, Regulatory | 1 | 2011 | 8 | 0.390 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2023 | 445 | 0.390 |
Why?
|
| Antibody Diversity | 1 | 2011 | 25 | 0.390 |
Why?
|
| Genes, Immunoglobulin | 1 | 2011 | 111 | 0.370 |
Why?
|
| Graft Survival | 5 | 2017 | 900 | 0.360 |
Why?
|
| T-Lymphocytes | 6 | 2020 | 1224 | 0.350 |
Why?
|
| Antigens | 3 | 2017 | 229 | 0.330 |
Why?
|
| Mice, Transgenic | 8 | 2021 | 1574 | 0.330 |
Why?
|
| Immune Tolerance | 1 | 2011 | 339 | 0.330 |
Why?
|
| Lymphocyte Activation | 5 | 2016 | 751 | 0.320 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 5 | 2013 | 14 | 0.320 |
Why?
|
| Immunoglobulins | 3 | 2013 | 144 | 0.310 |
Why?
|
| PAX5 Transcription Factor | 2 | 2012 | 33 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 10 | 2020 | 1088 | 0.290 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 595 | 0.280 |
Why?
|
| Cell Lineage | 3 | 2016 | 291 | 0.270 |
Why?
|
| Viral Envelope Proteins | 2 | 1998 | 94 | 0.270 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 1431 | 0.270 |
Why?
|
| DNA-Binding Proteins | 5 | 2020 | 1242 | 0.270 |
Why?
|
| T-Lymphocyte Subsets | 3 | 1998 | 275 | 0.270 |
Why?
|
| Abatacept | 2 | 2016 | 85 | 0.260 |
Why?
|
| Recombination, Genetic | 2 | 2022 | 445 | 0.260 |
Why?
|
| Cytidine Deaminase | 4 | 2022 | 43 | 0.260 |
Why?
|
| Th2 Cells | 2 | 2020 | 147 | 0.260 |
Why?
|
| Immunosuppressive Agents | 3 | 2016 | 975 | 0.260 |
Why?
|
| Endosomes | 2 | 2017 | 79 | 0.260 |
Why?
|
| CTLA-4 Antigen | 2 | 2016 | 139 | 0.240 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2004 | 40 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 12 | 2017 | 3218 | 0.220 |
Why?
|
| Dendritic Cells | 4 | 2020 | 449 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2017 | 2001 | 0.210 |
Why?
|
| Ribonucleases | 1 | 2022 | 94 | 0.210 |
Why?
|
| Isoantigens | 2 | 2020 | 71 | 0.200 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2020 | 171 | 0.190 |
Why?
|
| Ikaros Transcription Factor | 1 | 2020 | 25 | 0.190 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2020 | 19 | 0.170 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2017 | 165 | 0.170 |
Why?
|
| Allografts | 3 | 2015 | 181 | 0.170 |
Why?
|
| Th17 Cells | 1 | 2020 | 85 | 0.170 |
Why?
|
| Antigen Presentation | 3 | 1998 | 215 | 0.170 |
Why?
|
| Peptide Fragments | 2 | 2012 | 463 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 1265 | 0.160 |
Why?
|
| Chromatin | 1 | 2021 | 397 | 0.160 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 274 | 0.150 |
Why?
|
| CD79 Antigens | 1 | 2017 | 17 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 14 | 0.150 |
Why?
|
| Encephalitis, Viral | 1 | 1997 | 7 | 0.150 |
Why?
|
| Nucleotide Motifs | 1 | 2017 | 49 | 0.150 |
Why?
|
| Ubiquitination | 1 | 2017 | 73 | 0.150 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 1157 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2012 | 299 | 0.140 |
Why?
|
| Immunization | 1 | 2017 | 160 | 0.140 |
Why?
|
| Simplexvirus | 2 | 1997 | 151 | 0.140 |
Why?
|
| Interleukin-2 | 1 | 2017 | 251 | 0.140 |
Why?
|
| Humans | 19 | 2022 | 89357 | 0.140 |
Why?
|
| Kidney Transplantation | 2 | 2014 | 850 | 0.140 |
Why?
|
| Herpesvirus 1, Human | 1 | 1998 | 244 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1652 | 0.130 |
Why?
|
| Protein Conformation | 1 | 1998 | 889 | 0.130 |
Why?
|
| Protein Binding | 2 | 2017 | 1488 | 0.130 |
Why?
|
| Proteins | 1 | 2021 | 787 | 0.130 |
Why?
|
| Herpes Simplex | 1 | 1997 | 203 | 0.130 |
Why?
|
| Cell Line | 2 | 2017 | 2496 | 0.130 |
Why?
|
| Immunoconjugates | 1 | 2016 | 113 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 394 | 0.120 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2022 | 31 | 0.120 |
Why?
|
| Binding Sites | 1 | 2017 | 1117 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 319 | 0.120 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2014 | 20 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2014 | 36 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1412 | 0.110 |
Why?
|
| HLA Antigens | 1 | 2015 | 227 | 0.110 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2013 | 14 | 0.110 |
Why?
|
| Vaccines, Subunit | 1 | 2013 | 55 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2013 | 44 | 0.110 |
Why?
|
| CD40 Ligand | 1 | 2013 | 69 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 65 | 0.110 |
Why?
|
| Nanofibers | 1 | 2013 | 32 | 0.110 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2013 | 44 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 149 | 0.110 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2013 | 63 | 0.100 |
Why?
|
| Neutrophils | 2 | 2012 | 308 | 0.100 |
Why?
|
| Transplantation, Homologous | 4 | 2017 | 996 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2013 | 274 | 0.100 |
Why?
|
| Trans-Activators | 2 | 2013 | 443 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 1 | 2013 | 168 | 0.100 |
Why?
|
| Protein Kinase C | 1 | 2013 | 268 | 0.100 |
Why?
|
| Interferon-gamma | 3 | 2020 | 451 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 313 | 0.100 |
Why?
|
| Interleukin-7 | 1 | 2012 | 41 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 98 | 0.100 |
Why?
|
| Phenotype | 2 | 2016 | 2440 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 2558 | 0.100 |
Why?
|
| Mathematical Computing | 1 | 2011 | 21 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 665 | 0.100 |
Why?
|
| Myeloid Cells | 1 | 2012 | 100 | 0.100 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2011 | 32 | 0.090 |
Why?
|
| Systems Biology | 1 | 2011 | 44 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 695 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 153 | 0.090 |
Why?
|
| Peptides | 1 | 2013 | 648 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2012 | 471 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2366 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 740 | 0.080 |
Why?
|
| Cell Movement | 2 | 2017 | 784 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 2062 | 0.070 |
Why?
|
| Lung | 1 | 2013 | 1263 | 0.070 |
Why?
|
| Male | 7 | 2020 | 42411 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2012 | 2884 | 0.060 |
Why?
|
| Female | 7 | 2020 | 46202 | 0.060 |
Why?
|
| Endocytosis | 2 | 2017 | 180 | 0.060 |
Why?
|
| Asthma | 1 | 2013 | 978 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 465 | 0.060 |
Why?
|
| Germ Cells | 1 | 2005 | 130 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 116 | 0.060 |
Why?
|
| Models, Biological | 1 | 2011 | 1765 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 94 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 160 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2004 | 112 | 0.060 |
Why?
|
| CD18 Antigens | 1 | 2023 | 22 | 0.060 |
Why?
|
| Algorithms | 1 | 2011 | 1877 | 0.050 |
Why?
|
| Genome | 1 | 2006 | 386 | 0.050 |
Why?
|
| Cytokines | 2 | 2020 | 803 | 0.050 |
Why?
|
| Body Patterning | 1 | 2005 | 216 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2004 | 111 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2004 | 426 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2022 | 80 | 0.050 |
Why?
|
| Lymphoma | 1 | 2004 | 265 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 94 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2015 | 8241 | 0.050 |
Why?
|
| Culture Media | 1 | 2021 | 147 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2004 | 458 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 106 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 104 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1799 | 0.050 |
Why?
|
| DNA | 1 | 2006 | 1308 | 0.040 |
Why?
|
| Peptidoglycan | 1 | 2020 | 31 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 207 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 704 | 0.040 |
Why?
|
| Inflammation | 3 | 2013 | 972 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2020 | 274 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 1998 | 16 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 1998 | 18 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 1998 | 29 | 0.040 |
Why?
|
| Monocytes | 1 | 2020 | 218 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 293 | 0.040 |
Why?
|
| Carbohydrates | 1 | 1998 | 47 | 0.040 |
Why?
|
| CHO Cells | 1 | 1998 | 187 | 0.040 |
Why?
|
| Clone Cells | 1 | 1998 | 214 | 0.040 |
Why?
|
| Virus Diseases | 1 | 1999 | 98 | 0.040 |
Why?
|
| Liver | 1 | 2023 | 1208 | 0.040 |
Why?
|
| Viruses | 1 | 1999 | 78 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 1998 | 88 | 0.040 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2017 | 15 | 0.040 |
Why?
|
| Cricetinae | 1 | 1998 | 558 | 0.040 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2017 | 54 | 0.040 |
Why?
|
| Granzymes | 1 | 2017 | 94 | 0.040 |
Why?
|
| Keratitis, Herpetic | 1 | 1997 | 9 | 0.040 |
Why?
|
| Trigeminal Ganglion | 1 | 1997 | 16 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2017 | 96 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 92 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2017 | 105 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2016 | 14 | 0.030 |
Why?
|
| Integrases | 1 | 2016 | 62 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 65 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 144 | 0.030 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2015 | 11 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Virus Replication | 1 | 1997 | 324 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 895 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2014 | 80 | 0.030 |
Why?
|
| Schistosomiasis | 1 | 1994 | 5 | 0.030 |
Why?
|
| Thy-1 Antigens | 1 | 1994 | 16 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1534 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1994 | 100 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2013 | 5 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 96 | 0.030 |
Why?
|
| Protein Kinase C-theta | 1 | 2013 | 16 | 0.030 |
Why?
|
| B7-2 Antigen | 1 | 2013 | 40 | 0.030 |
Why?
|
| Arthritis | 1 | 1994 | 47 | 0.030 |
Why?
|
| Models, Immunological | 1 | 1994 | 81 | 0.030 |
Why?
|
| B7-1 Antigen | 1 | 2013 | 76 | 0.030 |
Why?
|
| Listeriosis | 1 | 1994 | 86 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 77 | 0.030 |
Why?
|
| Mites | 1 | 2013 | 16 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1994 | 237 | 0.030 |
Why?
|
| Rituximab | 1 | 2013 | 119 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 91 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 172 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 433 | 0.030 |
Why?
|
| Epitopes | 1 | 2013 | 255 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2012 | 35 | 0.030 |
Why?
|
| Syndecan-1 | 1 | 2012 | 16 | 0.030 |
Why?
|
| Complement C4b | 1 | 2012 | 32 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 421 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2014 | 309 | 0.030 |
Why?
|
| Interleukins | 1 | 2013 | 129 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2012 | 134 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 24 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2013 | 151 | 0.030 |
Why?
|
| Collagen | 1 | 1994 | 293 | 0.030 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2011 | 18 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 198 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2011 | 47 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 262 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 1849 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 275 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2012 | 166 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 171 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2011 | 148 | 0.020 |
Why?
|
| Base Sequence | 1 | 1994 | 2327 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 892 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 851 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 466 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 640 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 3027 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1184 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2011 | 322 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 956 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 5338 | 0.020 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2006 | 17 | 0.020 |
Why?
|
| Mathematics | 1 | 2006 | 191 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2006 | 92 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 4289 | 0.020 |
Why?
|
| Limb Buds | 1 | 2005 | 7 | 0.020 |
Why?
|
| Branchial Region | 1 | 2005 | 16 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 557 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 25974 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 421 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 26607 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2006 | 491 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2005 | 590 | 0.010 |
Why?
|
| Placenta | 1 | 2005 | 179 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 571 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 540 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 280 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 1995 | 20 | 0.010 |
Why?
|
| Lymphokines | 1 | 1995 | 76 | 0.010 |
Why?
|
| CD28 Antigens | 1 | 1995 | 90 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1995 | 84 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 352 | 0.010 |
Why?
|
| Immunity | 1 | 1995 | 141 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 1995 | 183 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1995 | 201 | 0.010 |
Why?
|